Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

T-Up, Inc.

This article was originally published in The Tan Sheet

Executive Summary

Baltimore firm and its principals are appealing a $3.7 mil. fine by the Maryland Attorney General for making claims their aloe vera and mineral health products cure diseases such as cancer and AIDS. T-Up products were marketed for oral consumption or IV administration without FDA approval and lacked adequate safety and efficacy data, the AG asserted. T-Up, President Allen Hoffman and two others were indicted in July 1999 on federal charges of conspiracy, mail and wire fraud and introducing an unapproved new drug into commerce. A Baltimore federal jury on June 15 deadlocked on all but one charge against the firm and Hoffman, finding them not guilty on one mail fraud count. The jury found an Oklahoma supplier of the products not guilty on all counts
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS091391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel